These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 23316302

  • 1. Protein kinase g iα inhibits pressure overload-induced cardiac remodeling and is required for the cardioprotective effect of sildenafil in vivo.
    Blanton RM, Takimoto E, Lane AM, Aronovitz M, Piotrowski R, Karas RH, Kass DA, Mendelsohn ME.
    J Am Heart Assoc; 2012 Oct; 1(5):e003731. PubMed ID: 23316302
    [Abstract] [Full Text] [Related]

  • 2. Sacubitril/Valsartan Improves Left Ventricular Function in Chronic Pressure Overload Independent of Intact Cyclic Guanosine Monophosphate-dependent Protein Kinase I Alpha Signaling.
    Tam K, Richards DA, Aronovitz MJ, Martin GL, Pande S, Jaffe IZ, Blanton RM.
    J Card Fail; 2020 Sep; 26(9):769-775. PubMed ID: 32464187
    [Abstract] [Full Text] [Related]

  • 3. Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo.
    Westermann D, Becher PM, Lindner D, Savvatis K, Xia Y, Fröhlich M, Hoffmann S, Schultheiss HP, Tschöpe C.
    Basic Res Cardiol; 2012 Nov; 107(6):308. PubMed ID: 23117837
    [Abstract] [Full Text] [Related]

  • 4. Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload.
    Nagayama T, Hsu S, Zhang M, Koitabashi N, Bedja D, Gabrielson KL, Takimoto E, Kass DA.
    J Am Coll Cardiol; 2009 Jan 13; 53(2):207-15. PubMed ID: 19130990
    [Abstract] [Full Text] [Related]

  • 5. CRD-733, a Novel PDE9 (Phosphodiesterase 9) Inhibitor, Reverses Pressure Overload-Induced Heart Failure.
    Richards DA, Aronovitz MJ, Liu P, Martin GL, Tam K, Pande S, Karas RH, Bloomfield DM, Mendelsohn ME, Blanton RM.
    Circ Heart Fail; 2021 Jan 13; 14(1):e007300. PubMed ID: 33464954
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway.
    Hsu S, Nagayama T, Koitabashi N, Zhang M, Zhou L, Bedja D, Gabrielson KL, Molkentin JD, Kass DA, Takimoto E.
    Cardiovasc Res; 2009 Feb 01; 81(2):301-9. PubMed ID: 19029137
    [Abstract] [Full Text] [Related]

  • 8. Chronic inhibition of cGMP-specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure.
    Gong W, Duan Q, Cai Z, Chen C, Ni L, Yan M, Wang X, Cianflone K, Wang DW.
    Br J Pharmacol; 2013 Dec 01; 170(7):1396-409. PubMed ID: 24032459
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of mitochondrial creatine kinase preserves cardiac energetics without ameliorating murine chronic heart failure.
    Cao F, Maguire ML, McAndrew DJ, Lake HA, Neubauer S, Zervou S, Schneider JE, Lygate CA.
    Basic Res Cardiol; 2020 Jan 10; 115(2):12. PubMed ID: 31925563
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide synthase 3 deficiency limits adverse ventricular remodeling after pressure overload in insulin resistance.
    Kurtz B, Thibault HB, Raher MJ, Popovich JR, Cawley S, Atochin DN, Hayton S, Shakartzi HR, Huang PL, Bloch KD, Buys E, Scherrer-Crosbie M.
    Am J Physiol Heart Circ Physiol; 2011 Nov 10; 301(5):H2093-101. PubMed ID: 21856905
    [Abstract] [Full Text] [Related]

  • 11. Cytosolic DNA sensor cGAS plays an essential pathogenetic role in pressure overload-induced heart failure.
    Hu D, Cui YX, Wu MY, Li L, Su LN, Lian Z, Chen H.
    Am J Physiol Heart Circ Physiol; 2020 Jun 01; 318(6):H1525-H1537. PubMed ID: 32383996
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oxidative stress regulates left ventricular PDE5 expression in the failing heart.
    Lu Z, Xu X, Hu X, Lee S, Traverse JH, Zhu G, Fassett J, Tao Y, Zhang P, dos Remedios C, Pritzker M, Hall JL, Garry DJ, Chen Y.
    Circulation; 2010 Apr 06; 121(13):1474-83. PubMed ID: 20308615
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
    Ruetten H, Dimmeler S, Gehring D, Ihling C, Zeiher AM.
    Cardiovasc Res; 2005 Jun 01; 66(3):444-53. PubMed ID: 15914109
    [Abstract] [Full Text] [Related]

  • 16. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
    Abe I, Terabayashi T, Hanada K, Kondo H, Teshima Y, Ishii Y, Miyoshi M, Kira S, Saito S, Tsuchimochi H, Shirai M, Yufu K, Arakane M, Daa T, Thumkeo D, Narumiya S, Takahashi N, Ishizaki T.
    Cardiovasc Res; 2021 Mar 21; 117(4):1103-1117. PubMed ID: 32647865
    [Abstract] [Full Text] [Related]

  • 17. Effects of adiponectin deficiency on structural and metabolic remodeling in mice subjected to pressure overload.
    O'Shea KM, Chess DJ, Khairallah RJ, Rastogi S, Hecker PA, Sabbah HN, Walsh K, Stanley WC.
    Am J Physiol Heart Circ Physiol; 2010 Jun 21; 298(6):H1639-45. PubMed ID: 20348222
    [Abstract] [Full Text] [Related]

  • 18. Selective Inhibition of NLRP3 Inflammasome Reverses Pressure Overload-Induced Pathological Cardiac Remodeling by Attenuating Hypertrophy, Fibrosis, and Inflammation.
    Zhao M, Zhang J, Xu Y, Liu J, Ye J, Wang Z, Ye D, Feng Y, Xu S, Pan W, Wang M, Wan J.
    Int Immunopharmacol; 2021 Oct 21; 99():108046. PubMed ID: 34435581
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice.
    Takimoto E, Koitabashi N, Hsu S, Ketner EA, Zhang M, Nagayama T, Bedja D, Gabrielson KL, Blanton R, Siderovski DP, Mendelsohn ME, Kass DA.
    J Clin Invest; 2009 Feb 21; 119(2):408-20. PubMed ID: 19127022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.